Cannabis: In Focus
- SAFE Banking Updates
- New Hampshire Senate Rejects Legalization Bill for Adult-Use Cannabis
- Sixth Circuit Reverses Dismissal of Suit Brought by CBD Shop Owner
YOUR GUIDE TO THE LEGAL PRESENT AND FUTURE OF THE CANNABIS INDUSTRY
Cannabis: In Focus
…
Continue Reading Cannabis Legal Report—Week of May 22, 2023
Cannabis: In Focus
…
Continue Reading Cannabis Legal Report—Week of May 8, 2023
Cannabis: In Focus
…
Continue Reading Cannabis Legal Report—Week of April 24, 2023
Cannabis: In Focus
…
Continue Reading Cannabis Legal Report—Week of April 17, 2023
Cannabis: In Focus
…
Continue Reading Cannabis Legal Report—Week of March 20, 2023
Cannabis: In Focus
DEA Classifies Two Lab-Derived Cannabinoids as Schedule I
The U.S. Drug Enforcement Administration (DEA) determined that two lab-derived cannabinoids— delta-8 THC acetate ester (delta-8 THCO) and delta-9 acetate ester (delta-9 THCO)—do not meet the federal definition…
Cannabis: In Focus
…
Continue Reading Cannabis Legal Report—Week of February 13, 2023
Cannabis: In Focus
…
Continue Reading Cannabis Legal Report—Week of January 30, 2023
The District Court for the Western District of New York denied a motion on January 6, 2023, to dismiss claims alleging that a publicly traded company misled investors regarding an investigation by the U.S. Securities and Exchange Commission (SEC). The company, 22nd Century, engineers cannabis plants to regulate their levels of cannabinoids. The court’s denial of the motion to dismiss is an important reminder to companies, especially those in the cannabis space, about the importance of compliance and disclosure.…
Continue Reading New York Cannabis Co. Investor Suit Survives Motion To Dismiss
Cannabis: In Focus
…
Continue Reading Cannabis Legal Report – Week of October 3, 2022